Logo image of PSEC

PROSPECT CAPITAL CORP (PSEC) Stock Fundamental Analysis

NASDAQ:PSEC - Nasdaq - US74348T1025 - Common Stock - Currency: USD

3.24  -0.04 (-1.22%)

After market: 3.25 +0.01 (+0.31%)

Fundamental Rating

3

PSEC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 231 industry peers in the Capital Markets industry. PSEC has a medium profitability rating, but doesn't score so well on its financial health evaluation. PSEC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year PSEC was profitable.
PSEC had a positive operating cash flow in the past year.
In multiple years PSEC reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: PSEC reported negative operating cash flow in multiple years.
PSEC Yearly Net Income VS EBIT VS OCF VS FCFPSEC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

PSEC's Return On Assets of -1.26% is on the low side compared to the rest of the industry. PSEC is outperformed by 78.36% of its industry peers.
Looking at the Return On Equity, with a value of -1.80%, PSEC is doing worse than 76.62% of the companies in the same industry.
PSEC has a Return On Invested Capital (4.14%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for PSEC is below the industry average of 7.24%.
The last Return On Invested Capital (4.14%) for PSEC is above the 3 year average (4.06%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.26%
ROE -1.8%
ROIC 4.14%
ROA(3y)2.32%
ROA(5y)4.38%
ROE(3y)3.67%
ROE(5y)6.97%
ROIC(3y)4.06%
ROIC(5y)3.98%
PSEC Yearly ROA, ROE, ROICPSEC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

PSEC's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 46.92%, PSEC belongs to the top of the industry, outperforming 83.12% of the companies in the same industry.
In the last couple of years the Operating Margin of PSEC has grown nicely.
PSEC has a Gross Margin of 52.94%. This is in the better half of the industry: PSEC outperforms 61.04% of its industry peers.
In the last couple of years the Gross Margin of PSEC has grown nicely.
Industry RankSector Rank
OM 46.92%
PM (TTM) N/A
GM 52.94%
OM growth 3Y2.53%
OM growth 5Y1.85%
PM growth 3Y-51.74%
PM growth 5Y-3.58%
GM growth 3Y2.62%
GM growth 5Y1.89%
PSEC Yearly Profit, Operating, Gross MarginsPSEC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

3

2. Health

2.1 Basic Checks

Compared to 1 year ago, PSEC has more shares outstanding
PSEC has more shares outstanding than it did 5 years ago.
PSEC has a better debt/assets ratio than last year.
PSEC Yearly Shares OutstandingPSEC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
PSEC Yearly Total Debt VS Total AssetsPSEC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.52, we must say that PSEC is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.52, PSEC is not doing good in the industry: 63.64% of the companies in the same industry are doing better.
PSEC has a debt to FCF ratio of 3.69. This is a good value and a sign of high solvency as PSEC would need 3.69 years to pay back of all of its debts.
The Debt to FCF ratio of PSEC (3.69) is better than 71.43% of its industry peers.
PSEC has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
PSEC's Debt to Equity ratio of 0.41 is fine compared to the rest of the industry. PSEC outperforms 72.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 3.69
Altman-Z 0.52
ROIC/WACCN/A
WACCN/A
PSEC Yearly LT Debt VS Equity VS FCFPSEC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

2.3 Liquidity

A Current Ratio of 0.59 indicates that PSEC may have some problems paying its short term obligations.
PSEC has a worse Current ratio (0.59) than 71.86% of its industry peers.
PSEC has a Quick Ratio of 0.59. This is a bad value and indicates that PSEC is not financially healthy enough and could expect problems in meeting its short term obligations.
PSEC has a worse Quick ratio (0.59) than 71.86% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.59
PSEC Yearly Current Assets VS Current LiabilitesPSEC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1

3. Growth

3.1 Past

The earnings per share for PSEC have decreased strongly by -21.00% in the last year.
The Earnings Per Share has been growing slightly by 2.68% on average over the past years.
The Revenue has been growing slightly by 1.11% in the past year.
The Revenue has been growing slightly by 4.13% on average over the past years.
EPS 1Y (TTM)-21%
EPS 3Y9.44%
EPS 5Y2.68%
EPS Q2Q%-43.48%
Revenue 1Y (TTM)1.11%
Revenue growth 3Y10.89%
Revenue growth 5Y4.13%
Sales Q2Q%-15.58%

3.2 Future

PSEC is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.25% yearly.
The Revenue is expected to decrease by -10.61% on average over the next years. This is quite bad
EPS Next Y-41.11%
EPS Next 2Y-29.7%
EPS Next 3Y-23.25%
EPS Next 5YN/A
Revenue Next Year-15.84%
Revenue Next 2Y-13.61%
Revenue Next 3Y-10.61%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PSEC Yearly Revenue VS EstimatesPSEC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
PSEC Yearly EPS VS EstimatesPSEC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.10, the valuation of PSEC can be described as very cheap.
Based on the Price/Earnings ratio, PSEC is valued cheaply inside the industry as 96.10% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.20, PSEC is valued rather cheaply.
PSEC is valuated cheaply with a Price/Forward Earnings ratio of 6.76.
Based on the Price/Forward Earnings ratio, PSEC is valued cheaper than 90.91% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, PSEC is valued rather cheaply.
Industry RankSector Rank
PE 4.1
Fwd PE 6.76
PSEC Price Earnings VS Forward Price EarningsPSEC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PSEC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PSEC is cheaper than 89.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.62
EV/EBITDA N/A
PSEC Per share dataPSEC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as PSEC's earnings are expected to decrease with -23.25% in the coming years.
PEG (NY)N/A
PEG (5Y)1.53
EPS Next 2Y-29.7%
EPS Next 3Y-23.25%

5

5. Dividend

5.1 Amount

PSEC has a Yearly Dividend Yield of 14.63%, which is a nice return.
In the last 3 months the price of PSEC has falen by -26.36%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
PSEC's Dividend Yield is rather good when compared to the industry average which is at 8.17. PSEC pays more dividend than 90.91% of the companies in the same industry.
PSEC's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 14.63%

5.2 History

The dividend of PSEC has a limited annual growth rate of 5.35%.
PSEC has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.35%
Div Incr Years0
Div Non Decr Years0
PSEC Yearly Dividends per sharePSEC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

PSEC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-404.93%
EPS Next 2Y-29.7%
EPS Next 3Y-23.25%
PSEC Yearly Income VS Free CF VS DividendPSEC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

PROSPECT CAPITAL CORP

NASDAQ:PSEC (5/29/2025, 8:06:46 PM)

After market: 3.25 +0.01 (+0.31%)

3.24

-0.04 (-1.22%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-26 2025-08-26/amc
Inst Owners10.79%
Inst Owner Change29.01%
Ins Owners18.55%
Ins Owner Change4.11%
Market Cap1.46B
Analysts40
Price Target3.57 (10.19%)
Short Float %7.3%
Short Ratio7.35
Dividend
Industry RankSector Rank
Dividend Yield 14.63%
Yearly Dividend0.87
Dividend Growth(5Y)5.35%
DP-404.93%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-27 2025-08-27 (0.045)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.58%
Min EPS beat(2)21.11%
Max EPS beat(2)40.06%
EPS beat(4)4
Avg EPS beat(4)27.52%
Min EPS beat(4)12.75%
Max EPS beat(4)40.06%
EPS beat(8)8
Avg EPS beat(8)20.9%
EPS beat(12)12
Avg EPS beat(12)19.72%
EPS beat(16)16
Avg EPS beat(16)18.35%
Revenue beat(2)0
Avg Revenue beat(2)-5.07%
Min Revenue beat(2)-6.01%
Max Revenue beat(2)-4.14%
Revenue beat(4)1
Avg Revenue beat(4)-4.07%
Min Revenue beat(4)-7.33%
Max Revenue beat(4)1.21%
Revenue beat(8)3
Avg Revenue beat(8)-9.72%
Revenue beat(12)6
Avg Revenue beat(12)-5.57%
Revenue beat(16)9
Avg Revenue beat(16)-3.76%
PT rev (1m)-12.5%
PT rev (3m)-12.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-1.08%
Valuation
Industry RankSector Rank
PE 4.1
Fwd PE 6.76
P/S 1.84
P/FCF 2.62
P/OCF 2.62
P/B 0.29
P/tB 0.29
EV/EBITDA N/A
EPS(TTM)0.79
EY24.38%
EPS(NY)0.48
Fwd EY14.8%
FCF(TTM)1.24
FCFY38.12%
OCF(TTM)1.24
OCFY38.12%
SpS1.76
BVpS11.23
TBVpS11.23
PEG (NY)N/A
PEG (5Y)1.53
Profitability
Industry RankSector Rank
ROA -1.26%
ROE -1.8%
ROCE 5.24%
ROIC 4.14%
ROICexc 4.18%
ROICexgc 4.18%
OM 46.92%
PM (TTM) N/A
GM 52.94%
FCFM 70.04%
ROA(3y)2.32%
ROA(5y)4.38%
ROE(3y)3.67%
ROE(5y)6.97%
ROIC(3y)4.06%
ROIC(5y)3.98%
ROICexc(3y)4.1%
ROICexc(5y)4.01%
ROICexgc(3y)4.1%
ROICexgc(5y)4.01%
ROCE(3y)5.14%
ROCE(5y)5.03%
ROICexcg growth 3Y5.53%
ROICexcg growth 5Y-0.41%
ROICexc growth 3Y5.53%
ROICexc growth 5Y-0.41%
OM growth 3Y2.53%
OM growth 5Y1.85%
PM growth 3Y-51.74%
PM growth 5Y-3.58%
GM growth 3Y2.62%
GM growth 5Y1.89%
F-Score3
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 3.69
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.56
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.59
Quick Ratio 0.59
Altman-Z 0.52
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21%
EPS 3Y9.44%
EPS 5Y2.68%
EPS Q2Q%-43.48%
EPS Next Y-41.11%
EPS Next 2Y-29.7%
EPS Next 3Y-23.25%
EPS Next 5YN/A
Revenue 1Y (TTM)1.11%
Revenue growth 3Y10.89%
Revenue growth 5Y4.13%
Sales Q2Q%-15.58%
Revenue Next Year-15.84%
Revenue Next 2Y-13.61%
Revenue Next 3Y-10.61%
Revenue Next 5YN/A
EBIT growth 1Y-14.59%
EBIT growth 3Y13.69%
EBIT growth 5Y6.06%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y180.7%
FCF growth 3Y108.25%
FCF growth 5Y4.58%
OCF growth 1Y180.7%
OCF growth 3Y108.25%
OCF growth 5Y4.58%